ImpactOS
See an example

Denali Therapeutics Inc

Companies and groups · United States

In these lists: Medicines

Declared lobbying cost
€400,000 – €499,999 Financial year 01/2025-12/2025
Commission meetings
0
Full-time staff on EU lobbying
1.05
European Parliament access passes
0
Registered since
21 Oct 2025
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Business and industry, Public health, Research and innovation, Trade

Medicines and food topics they name

EU medicines law

EU laws and policies they declare following1
  • We follow EU initiatives, policies and legislative files related to our Pharmaceuticals businesses. This includes topics such as drug research and development, clinical trials, data protection, relev…

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

No published meetings with the current Commissioners since 1 December 2024

Official entries

Name in the register: Denali Therapeutics Inc.

Checked against sources on 11 Nov 2026